Besunyen Holdings Company Limited (the “Company”) was established in September 2000 and listed on the Main Board of the Hong Kong Stock Exchange in September 2010 (stock code: HK00926). Besunyen Holdings Company Limited together with its subsidiaries (the “Group”) is a leading provider of therapeutic teas in the People’s  Republic  of  China  (the “PRC”), mainly engaging in the research and development and production of health products  and the sale and promotion of medicines and food products. The Group applies “One Focus and Two Dimensions” as its guiding principle: “One  Focus” means focusing on herbs and health regimen; and  “Two Dimensions” means expanding  new  businesses in the areas of “weight loss and weight management” as well as “laxative and gastrointestinal health”. By tagging along with the concept of “herbal, healthy, and quality functional tea”, the Group has produced and sold Besunyen  Detox Tea (碧生源牌常潤茶) and Besunyen Slimming Tea (碧生源牌常菁茶) (previously known as “碧生源牌減肥茶”) (collectively, the “Two Teas”) for more than twenty years. The Group has dedicated itself to further developing the Two Teas and successively launching its product series of functional teas such as Besunyen Fit Tea (碧生源牌纖纖茶) and Besunyen Relief Tea (碧生源牌清源茶) (together with the Two Teas, the “Four Teas”). In recent years, the Group has also launched Besunyen Orlistat weight-loss medicines and a series of products that meet the needs of consumers, such as nutrition meal replacements, probiotics and enzymes.

The Group uses natural Chinese herbs and tea  leaves  as raw materials to research, develop, formulate and produce the Four Teas, providing safe, effective, convenient-to-use and affordable health products for those who have needs in aspects such as laxative and weight management or who are mildly affected  by such problems.

The production base of the Group’s Four Teas is located in Fangshan District, Beijing. Its production plant and production process are in compliance with the national GMP standards. Its production facilities implement closed-ended management, and its pelleting facilities and inner packing facilities are class 100,000 clean areas. The Group’s Four Teas products have passed the certifications of ISO9001, ISO22000 and HACCP. Introduced from IMA, an Italian company, its main production equipment is  C24  tea bag high-speed machine with specially designed “cotton thread sailor’s knot” connecting the tea bag and the hangtag, so that the  inner  and  outer  bags  and the outer box can be  shaped  up  at  the  same  time and whole packaging process can be completed automatically.

The Group’s “Besunyen and Device” trademark was identified as a “China Well-known Trademark” ( 中國馳名商標) by the Trademark Office of the State Administration for Industry & Commerce of the People’s Republic of China in 2013, and its Besunyen brand has been rated as one of the top ten credible brands of health products in China by China Healthcare Association for five consecutive years. The Group obtained the “High-Tech Enterprise Certificate” issued by Beijing Municipal Science and Technology Commission, and was granted the title of “Leading Enterprise in Beijing” issued by Beijing  Municipal Bureau of Agriculture and Rural Affairs as well as the titles of “‘Innovative’ Small and Medium-Sized Enterprise in Beijing” and “‘Specialized, Refined, Unique and Innovative’ Small and Medium-Sized Enterprise in Beijing” issued by Beijing Municipal Bureau of Economy and Information Technology. The Group has 25 approvals for health food issued by  China Food and Drug Administration, and it has possessed 117 patented technologies awarded  by China National Intellectual Property Administration, including 21 invention patents.

As at the end of 2024, the Group’s offline sales  business covered about 300,000 over-the-counter (“OTC”) pharmacies and pharmaceutical third terminals, spanning across 31 provinces, autonomous regions and municipalities across the country, through the new business partners. The Group’s online e-commerce business has established 63 shops on 18 e-commerce platforms to conduct the sales  of  the Four Teas, Orlistat and other products of the Group. Proactively adapting to the development of new sales trend, the Group made repeated attempts in  respect  of new retail including Douyin, Kuaishou,  O2O  and B2C. The above mature and innovative channels enabled the Group to launch its new products to the market more quickly, thereby maintaining the industrial leading position of the Group in terms of  sales of products.

The Group will continue its market-oriented approach while pursuing continuous innovation in terms of technology and quality, strive to provide consumers with more high-quality health products and services, and become a leader in the health industry.